Anterix (ATEX) Research & Development (2016 - 2025)
Historic Research & Development for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to $1.1 million.
- Anterix's Research & Development fell 142.86% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.5 million, marking a year-over-year decrease of 3431.56%. This contributed to the annual value of $5.7 million for FY2025, which is 66.7% up from last year.
- Latest data reveals that Anterix reported Research & Development of $1.1 million as of Q4 2025, which was down 142.86% from $1.2 million recorded in Q3 2025.
- Over the past 5 years, Anterix's Research & Development peaked at $2.2 million during Q1 2024, and registered a low of $767000.0 during Q1 2022.
- Its 5-year average for Research & Development is $1.2 million, with a median of $1.1 million in 2024.
- As far as peak fluctuations go, Anterix's Research & Development soared by 8604.95% in 2023, and later crashed by 5144.9% in 2025.
- Quarter analysis of 5 years shows Anterix's Research & Development stood at $893000.0 in 2021, then rose by 4.82% to $936000.0 in 2022, then surged by 32.26% to $1.2 million in 2023, then decreased by 9.53% to $1.1 million in 2024, then decreased by 1.43% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q4 2025, $1.2 million for Q3 2025, and $1.1 million during Q2 2025.